4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-026641
SVP, Chief Accounting Officer sold 341 shares at $53.76 ($18,332)
- SVP, Chief Accounting Officer gave up 121 shares (to pay taxes)
- SVP, Chief Accounting Officer acquired 13,950 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Chief Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 1 in the form | +13,950 | 41,842 | D | ||
| 2024-03-01 | Shares withheld for taxes : show line 2 in the form | −121 | $53.69 | $6,496 | 41,721 | D |
| 2024-03-01 | Sale : show line 3 in the form | −341 | $53.76 | $18,332 | 41,380 | D |
| Open-market sales · 341 sh · avg $53.76 · $18,332 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +8,200 | 8,200 | D |
| 2024-03-01 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +2,351 | 2,351 | D |
Loading xslF345X05/ownership.xml…